Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Convergence Partners is a European venture capital firm founded to invest in high-impact companies within the healthcare sector. Established in Switzerland, the firm focuses on addressing large unmet needs in healthcare. Convergence Partners aims to finance and scale innovative ideas globally, particularly in the HealthTech space.
The firm has a strong emphasis on supporting B2B-focused HealthTech companies that have commercialized their technologies. With a commitment to international growth, Convergence Partners seeks to enhance the healthcare landscape by investing in scalable, IP-driven business models.
Convergence Partners invests primarily in the healthcare sector, with a specific focus on mental and brain health, women's health, and human flourishing and longevity. The firm targets B2B-focused HealthTech companies that have already commercialized their technologies and are looking to accelerate their scale-up efforts.
Investment checks typically reach up to EUR 5 million initially, with additional capital reserved for follow-on investments. The firm emphasizes strong international growth potential and scalable business models, making it a strategic partner for startups aiming to address significant healthcare challenges.
Daniel Koppelkamm: Founder, Managing Partner & Investment Committee Member. He has extensive experience in healthcare investments and has led multiple successful funding rounds.
Raj Airey: Founding Partner & Investment Committee Member. Raj has a strong background in venture capital and healthcare innovation.
Pascal Joncour: Partner, Investment Committee Member. Pascal specializes in identifying high-potential healthcare startups.
Dr. Jenny Hao: Operating Partner. Dr. Hao brings expertise in clinical research and healthcare technology.
Volker Herrmann: Operating Partner. Volker has a background in operational management within healthcare companies.
Ulrich Wallenhorst: Operating Partner. Ulrich focuses on scaling healthcare innovations.
Shirley Choo: Investment Director & Investment Committee Member. Shirley has a strong track record in healthcare investments.
Elena Baltaga: Investment Director. Elena specializes in market analysis and investment strategy.
Dr. Laura Johnson: Venture Partner, Germany. Laura has a background in healthcare consulting.
Alexandra Sasha: Venture Partner. Alexandra focuses on European healthcare startups.
Yannick Ormen: Venture Partner, Switzerland. Yannick has experience in scaling healthcare technologies.
Boye Hartmann: Venture Partner, Nordics. Boye specializes in Nordic healthcare innovations.
Dr. Hanna Poikonen: Advisor. Dr. Poikonen has expertise in neuroscience and mental health.
Maryann Selfe: Advisor. Maryann focuses on women's health initiatives.
Prof. Olaf Blanke: Advisor. Prof. Blanke is a leading expert in brain health.
Dr. Michelle Tempest: Advisor. Dr. Tempest specializes in healthcare technology.
Dr. Martijn Arns: Advisor. Dr. Arns has a background in mental health research.
Prof. Dr. Anabel Ternès von Hattburg, Princess of Prussia: Advisor. She brings a unique perspective on healthcare innovation.
Prof. Johannes Passecker: Advisor. Prof. Passecker specializes in health technology assessment.
Dr. Iker Puente: Advisor. Dr. Puente focuses on healthcare data analytics.
To pitch Convergence Partners, founders should use the submission link provided on their website. It is advisable to include a detailed overview of the business model, market opportunity, and growth strategy in the pitch deck. Response times may vary, and warm introductions are preferred but not mandatory.
What are Convergence Partners' investment criteria?
Convergence Partners focuses on high-impact healthcare companies, particularly in the areas of mental health, women's health, and longevity. They seek B2B HealthTech companies that have commercialized their technologies.
How much does Convergence Partners typically invest?
The firm typically invests up to EUR 5 million initially, with additional capital available for follow-on investments.
What makes Convergence Partners different from other VCs?
Convergence Partners emphasizes strong international growth potential and scalable, IP-driven business models, providing tailored support to portfolio companies in their scale-up efforts.
What is the geographic focus of Convergence Partners?
The firm primarily invests in European healthcare companies but is open to global opportunities that align with their investment thesis.
How can founders pitch to Convergence Partners?
Founders can submit their pitch through the submission link available on the Convergence Partners website. Specific details on what to include in the pitch are not provided, but a clear articulation of the business model and growth potential is advisable.
What kind of post-investment support does Convergence Partners provide?
The firm actively supports its portfolio companies in scaling their operations and accessing international markets, leveraging its expertise and network in the healthcare sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.